BIRMINGHAM, August 22, 2026, 13:05 CDT — Medical Properties Trust stands out for its 8.7% yield, with the REIT now confronting a refinancing amount nearly matching its own market value.
- Medical Properties Trust finished Friday at $4.12, marking a 1.4% decline over the week.
- The REIT’s upcoming $2.4 billion refinancing is close to its $2.46 billion equity valuation.
- The new debt features a 9.25% coupon rate, resulting in approximately $222 million in yearly interest payments.
- The annualized dividend of $0.36 offers a yield of 8.7% based on Friday’s closing price.
Medical Properties Trust, Inc. NYSE:MPT starts the week facing a notable dilemma. While its operating cash flow is on an upward trend and it offers a dividend yield of 8.7%, the hospital landlord has a $2.4 billion refinancing task ahead—almost matching the company’s current market capitalization.
Shares ended Friday at $4.12, rising 0.98% on the day. Despite this, they dropped 1.4% across the week and remain 12.3% lower than their close on August 7, just prior to the release of second-quarter results. The New York Stock Exchange is shut over the weekend.
| Date | Close | Volume |
|---|---|---|
| Aug. 14 | $4.18 | 7.05 million |
| Aug. 17 | $4.05 | 6.67 million |
| Aug. 18 | $4.02 | 8.27 million |
| Aug. 19 | $4.16 | 8.17 million |
| Aug. 20 | $4.08 | 6.13 million |
| Aug. 21 | $4.12 | 6.23 million |
The refinancing eases the most immediate pressure from MPT’s debt maturities. The firm intends to issue 9.25% senior secured notes maturing in 2032, fully redeem all 2026 notes, and pay down select debt maturing between 2027 and 2031.
The extension comes with a hefty price tag. Applying a 9.25% rate to $2.4 billion results in an estimated yearly coupon payment of $222 million. This amount represents roughly 60% of normalized funds from operations for the second quarter, annualized from the reported $92 million for the quarter.
| Refinancing measure | Amount | Investor context |
|---|---|---|
| New secured notes | $2.40 billion | 97.6% of Friday’s market capitalization |
| Coupon | 9.25% | Remains fixed until 2032 |
| Estimated annual interest | $222 million | Equal to 60% of annualized Q2 NFFO |
| Expected principal reduction | $123 million | Represents 5.1% of total refinancing |
| Debt after transaction | $9.515 billion | Roughly 3.9 times equity market cap |
| Unsecured maturities through 2028 | $1.30 billion | Following the refinancing |
MPT posted a net loss of $3 million for the second quarter, equal to one cent per share. Normalized funds from operations—a REIT cash-flow metric adjusted for property gains and additional items—climbed to $92 million, or 15 cents per share, compared with $81 million and 14 cents in the same period last year.
| Operating and income measure | Q2 2026 | Reference |
|---|---|---|
| Net income (loss) | ($3 million) | ($0.01) for each share |
| Normalized FFO | $92 million | $0.15 for each share |
| Normalized FFO, year earlier | $81 million | $0.14 for each share |
| Quarterly dividend | $0.09 for each share | 60% of Q2 NFFO per share |
| Annualized dividend | $0.36 for each share | 8.7% yield at $4.12 |
Chief Executive Edward Aldag stated that MPT was making “decisive steps to strengthen our balance sheet” via refinancing efforts and selling assets. The company anticipates around $172 million in third-quarter cash from previously announced sales. In addition, it received approximately $100 million from the Infracore listing and expects an additional $35 million during this quarter.
The primary draw continues to be the dividend. On August 13, MPT announced a regular quarterly payout of nine cents, set for payment on October 8 to shareholders of record as of September 10. The annual yield stands close to four percentage points higher than the 10-year Treasury yield observed by investors over much of the prior week.
Opinions among analysts are divided. Out of nine analysts, the consensus recommendation is Hold, with the mean price target at $5.21. This suggests an upside potential of 26.5% from Friday’s closing price, with target estimates ranging between $4.50 and $7.00. Recent target revisions reflect a similar split.
| Analyst or firm | Rating | Target | Implied move from $4.12 |
|---|---|---|---|
| Consensus from nine analysts | Hold | $5.21 | +26.5% |
| Bank of America | Sell | $4.25 | +3.2% |
| Barry Oxford, Colliers | Buy | $5.00 | +21.4% |
| Michael Diana, Maxim Group | Buy | $7.00 | +69.9% |
Healthcare property stocks led Friday’s rise. Alexandria Real Estate Equities, Inc. NYSE:ARE climbed 1.04%, and Healthpeak Properties, Inc. (NYSE:DOC) increased 0.94%. Boston Properties, Inc. (NYSE:BXP) edged down 0.16%. The S&P 500 advanced 0.43%.
As of June 30, MPT’s portfolio included 373 properties, approximately 38,000 licensed beds and 51 operators in nine countries. This level of diversification is significant, following bankruptcies among major tenants that demonstrated how swiftly rent issues can affect a highly leveraged landlord.
The risk is evident. Should planned asset disposals be delayed, rental income from tenants fall behind, or refinancing conditions worsen before deals close, MPT might be forced to seek more expensive funding. If the price remains consistently under the 52-week low of $3.96, it would further indicate that the current yield does not offset balance-sheet risk for investors.
Investors are set to monitor the refinancing closure and developments on third-quarter asset sales next week. The upcoming fixed dates include September 10, marking the dividend record, and October 8, the scheduled payment day. A key challenge remains: whether MPT can convert longer debt maturities to lighter leverage before the 9.25% coupon erodes any gain.
